Compliance Rate

Compliance Rate 51.23%
Compliant submissions 187
Incompliant submissions 178
Total trials 365

My Organizations' Clinical Trials

Showing 1525 of 2400 entries
View as:

A Randomized Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral (AR) Nucleoside Therapy in HIV-Infected Individuals With CD4+ Cell Counts Less Than or Equal to 200/mm3

Phase: N/A Priority: Normal
NCT ID: NCT00000859 Org: User:
Start: - End: 12/31/01 Due: 12/31/02

Detection of Human Immunodeficiency Virus Type 1 (HIV-1) in Vaginocervical Secretions: Correlation With Clinical Status, Virologic and Immunologic Parameters, and the Presence of Other Infections

Phase: N/A Priority: Normal
NCT ID: NCT00000858 Org: User:
Start: - End: - Due: -

A Trial of Two Doses of 2',3'-Dideoxycytidine (ddC) in the Treatment of Children With Symptomatic HIV Infection Who Are Intolerant of AZT and/or Who Show Progressive Disease While on AZT

Phase: N/A Priority: Normal
NCT ID: NCT00000653 Org: User:
Start: - End: 06/30/95 Due: 06/30/96

A Randomized, Double-Blind Phase II/III Trial of Monotherapy vs. Combination Therapy With Nucleoside Analogs in HIV-Infected Persons With CD4 Cells of 200-500/mm3

Phase: N/A Priority: Normal
NCT ID: NCT00000625 Org: User:
Start: - End: 11/30/95 Due: 11/30/96

A Study of the Effects of Giving Two Anti-HIV Vaccines to Babies of HIV-Positive Mothers

Phase: N/A Priority: Normal
NCT ID: NCT00000879 Org: User:
Start: - End: 04/30/05 Due: 04/30/06

A Study on the Effect of High-Calorie Infant Formula on Growth and Nutrition in HIV-Infected Infants

Phase: N/A Priority: Normal
NCT ID: NCT00000873 Org: User:
Start: - End: 09/30/05 Due: 09/30/06

A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients

Phase: N/A Priority: Normal
NCT ID: NCT00000896 Org: User:
Start: - End: 10/31/00 Due: 10/31/01

A Phase I Multicenter Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160

Phase: N/A Priority: Normal
NCT ID: NCT00000956 Org: User:
Start: - End: 03/31/93 Due: 03/31/94

A Pilot Study of the Short-Term Effects of Antiretroviral Management Based on Plasma Genotypic Antiretroviral Resistance Testing (GART) Compared With Antiretroviral Management Without Plasma GART

Phase: N/A Priority: Normal
NCT ID: NCT00000874 Org: User:
Start: 08/31/97 End: 03/31/99 Due: 03/31/00

A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis

Phase: N/A Priority: Normal
NCT ID: NCT00000698 Org: User:
Start: - End: 08/31/07 Due: 08/31/08

Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis

Phase: N/A Priority: Normal
NCT ID: NCT00000950 Org: User:
Start: - End: - Due: -

A Phase I Dose Escalation Study of Synthetic Hypericin in HIV-Infected Patients With Less Than 300 CD4 Lymphocytes

Phase: N/A Priority: Normal
NCT ID: NCT00000645 Org: User:
Start: - End: 10/31/94 Due: 10/31/95

A Study to Monitor Patients With Primary or Early HIV Infection

Phase: N/A Priority: Normal
NCT ID: NCT00000911 Org: User:
Start: 10/31/99 End: 06/30/07 Due: 06/30/08

Multi-center Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis

Phase: N/A Priority: Normal
NCT ID: NCT00000708 Org: User:
Start: - End: - Due: -

A Phase I Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160

Phase: N/A Priority: Normal
NCT ID: NCT00000745 Org: User:
Start: - End: 05/31/91 Due: 05/31/92

A Registry of Tuberculosis Cases in the CPCRA

Phase: N/A Priority: Normal
NCT ID: NCT00000785 Org: User:
Start: 08/31/92 End: 06/30/94 Due: 06/30/95

A Multicenter Dose Ranging Clinical Trial of 2',3'-Dideoxycytidine in the Treatment of Patients With AIDS and Advanced ARC.

Phase: N/A Priority: Normal
NCT ID: NCT00000704 Org: User:
Start: - End: 04/30/90 Due: 04/30/91

Single Dose Pharmacokinetics of Oral Dextran Sulfate (UA001) and Intravenous Dextran Sulfate in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00000690 Org: User:
Start: - End: 10/31/89 Due: 10/31/90

A Study of BufferGel in Women

Phase: N/A Priority: Normal
NCT ID: NCT00000927 Org: User:
Start: - End: - Due: -

Phase I Pharmacokinetic and Tolerance Study of Ribavirin in Human Immunodeficiency Virus (HIV) - Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00000733 Org: User:
Start: - End: 10/31/91 Due: 10/31/92

A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group

Phase: N/A Priority: Normal
NCT ID: NCT00000815 Org: User:
Start: - End: 08/31/01 Due: 08/31/02

A Randomized, Double-Blind Study of 566C80 Versus Septra (Sulfamethoxazole/Trimethoprim) for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients

Phase: N/A Priority: Normal
NCT ID: NCT00000655 Org: User:
Start: - End: - Due: -

A Phase I Study of Autologous, Activated CD8(+) Lymphocytes Expanded In Vitro and Infused With or Without Recombinant Interleukin-2 to Patients With AIDS or Severe ARC

Phase: N/A Priority: Normal
NCT ID: NCT00000680 Org: User:
Start: - End: 04/30/93 Due: 04/30/94

A Study to Test If Giving Remune (an HIV Vaccine) Can Improve the Immune Systems of HIV-Positive Patients Who Are Also Participating in ACTG 328

Phase: N/A Priority: Normal
NCT ID: NCT00000943 Org: User:
Start: - End: 11/30/05 Due: 11/30/06

A Study to Evaluate the Safety and Tolerability of Zidovudine (ZDV) in Premature Infants Born to HIV-Positive Women.

Phase: N/A Priority: Normal
NCT ID: NCT00000855 Org: User:
Start: - End: 02/29/00 Due: 02/28/01